Internal Medicine, Nephrology · Houston, TX
NPI
1497376461
Since 2020
Specialty
Internal Medicine, Nephrology
Code 207RN0300X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
6410 Fannin St Ste 600
Houston, TX, 77030
Phone (832) 325-6545
Groups this clinician bills Medicare through
Medicare paid, 2024
$5,108
86 services
Medicare patients, 2024
34
Average age 67
Drug cost, 2024
$212K
142 prescriptions
Company payments, 2025
$87.48
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Simon O Onuegbu was code 99233 (hospital e&m - subsequent), 33 times for 15 patients. In total Simon O Onuegbu billed 86 services in 11 codes, and Medicare paid $5,108.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-10-31.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99233 Hospital E&M - Subsequent | Facility | 33 | 15 | $78.72 | $2,598 |
| 99232 Hospital E&M - Subsequent | Facility | 32 | 16 | $52.28 | $1,673 |
By year: 2022 $4,760 for 89 services; 2023 $4,787 for 85 services; 2024 $5,108 for 86 services.
Medicare prescription drug claims, 2024
In 2024, the drug Simon O Onuegbu prescribed most often to Medicare patients was Hydroxyurea, with 21 prescriptions and refills. In total Simon O Onuegbu wrote 142 Medicare prescriptions that cost $212K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydroxyurea Generic | 21 | 29 | 13 | $445 |
| Adakveo Crizanlizumab-Tmca | 13 | 13 | Under 11 | $97K |
| Ibuprofen Generic | 11 | 11 | Under 11 | $27.11 |
Brand drugs: 36 claims; generic drugs: 106 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Simon O Onuegbu $87.48 ($87.48 in general payments such as food, travel and fees) from 3 companies. The largest payer was Amgen Inc. with $45.58.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.